The pharmaceutical executive who was arrested last week on securities-fraud charges has been fired from a second company in the wake of the allegations. Martin Shkreli, best known as the “pharma bro” who raised the price of an affordable AIDS-related drug by 5,000 percent, was removed Monday as chief executive of KaloBios Pharmaceuticals, a California biotech that he owned for the past month. KaloBios did not announce an interim successor. After his arrest last week, Shkreli was also ousted from Turing Pharmaceuticals, a New York-based company he co-founded a year ago.
